Precision and reliability define success

The demand for accurate, minimally invasive and patient-centric medical solutions is reshaping the industry. From point-of-care diagnostics to laser-based treatments and wearable monitoring devices, optical technologies are enabling a new generation of healthcare tools. But innovation alone is not enough. To reach patients safely and effectively, medical devices must demonstrate exceptional reliability and consistent performance – both in the lab and at scale. Bridging that gap between concept and commercial readiness is what defines success in today’s Medtech landscape.

Common hurdles on the path to market 

Translating a scientific concept into a manufacturable product requires deep interdisciplinary collaboration. Engineers and researchers must ensure that every optical component performs under clinical conditions, meets strict safety standards and integrates seamlessly into compact, often multifunctional systems. Meanwhile, compliance with medical regulations adds layers of complexity that can delay or derail even the most promising developments.

Scalability brings another layer of challenge: a design optimized for small-series prototyping may not hold up in industrial production. Maintaining optical precision, alignment and stability while optimizing cost and throughput requires both technical mastery and process discipline.

From co-development to industrialization

Building reliable optical products requires more than technical precision; it demands a development process that anticipates clinical, regulatory and production realities from the start. Successful teams integrate optical, mechanical and electronic design early on to ensure alignment with the medical application, whether diagnostic, therapeutic, or monitoring.

An end-to-end development model – from concept and prototyping through industrialization and manufacturing – helps ensure that every stage supports the next. By embedding reliability and regulatory compliance into the design process, medical device developers can minimize costly redesigns and accelerate the certification path. And when production is planned with scalability in mind, transitioning from pilot batches to serial manufacturing becomes smoother, maintaining optical performance and system integrity at every scale.

Advancing Medtech innovation with reliable optical systems

With decades of optical engineering expertise and proven CDMO capabilities, we help Medtech companies accelerate innovation and move confidently from prototype to production, delivering reliable, compliant and scalable products that improve patient outcomes.

Whether you’re a startup advancing a breakthrough technology or an established player scaling your next-generation device, we’re here to make optical precision your competitive advantage.

The post From prototype to production: Building reliable optical systems for next-gen medical devices appeared first on Verhaert Masters in Innovation.

The post From prototype to production: Building reliable optical systems for next-gen medical devices appeared first on Verhaert Masters in Innovation.

Raman Spectroscopy: A window into cell chemistry 

Raman spectroscopy allows researchers to explore the cells’ molecular makeup and their surroundings without the need for dyes or labels. It can pick up chemical details in the cell culture medium, but also, more importantly, within the cells themselves, revealing insights into lipids, proteins, or even DNA and RNA.

The challenge? Spontaneous Raman signals are naturally weak. This means that every photon counts. Instruments need to be engineered with care to minimize losses and keep detector noise tightly controlled. In this field, good biology depends on great optical systems to ensure meaningful data capture.

SRS and CARS: Speeding things up with nonlinear microscopy 

To overcome the limitations of spontaneous Raman, nonlinear optical microscopy (NLOM) techniques like Stimulated Raman Scattering (SRS) and Coherent Anti-Stokes Raman Scattering (CARS) have become increasingly popular. By enhancing the Raman signal several orders of magnitude, they make it possible to image living cells and tissues quickly, and still get rich, chemically specific information, without introducing any fluorescent labels.

Building systems like these is challenging, as they demand precise optical setups, ultrafast lasers, and signal optimization at every stage of the system. Their implementation is a multi-disciplinary effort, combining optics, electronics, and systems engineering to meet the stringent requirements of biological imaging.

These techniques are particularly relevant for studying dynamic cellular processes such as metabolism, cell differentiation, and disease progression. Being able to monitor and understand molecular changes in real time opens new doors for both research and medical diagnostics.

Putting it to the test: a BSL-1 lab for live-cell validation 

To support the refinement and application of such technologies, a Biosafety Level 1 (BSL-1) laboratory was established at Lambda-X Verhaert High-Tech. The lab provides a controlled environment to test and demonstrate microscopy systems in real biological conditions. This hands-on validation is particularly valuable for evaluating how advanced Raman-based imaging performs in live-cell scenarios, helping translate optical performance into biological relevance.

From research tools to process monitoring

While these technologies were first developed for fundamental research, their applications extend into areas like cell therapy, where understanding and controlling cell behavior is crucial. As such therapies move closer to clinical and industrial deployment, analytical tools based on nonlinear Raman microscopy offer potential for process monitoring, supporting quality control and decision-making during cell culture and expansion.

By combining advanced optical engineering with live-cell validation in the lab, nonlinear microscopy is shifting from a powerful research technique to a real enabler in next-generation cell research and therapeutic manufacturing.

Exploring advanced optical solutions for your imaging needs? Let’s talk how to collaborate on developing systems that align cutting-edge photonics with real biological applications.

The post Raman-based imaging in cell research: Bridging optics and biology appeared first on Verhaert Masters in Innovation.

The post Raman-based imaging in cell research: Bridging optics and biology appeared first on Verhaert Masters in Innovation.

Why the shift to automated microscopy?

The transition from manual to automated microscopy addresses a critical need: tackling tasks that are too complex or time-consuming for humans alone, such as counting cells in biotech applications to evaluate medicine effectiveness or measure cell growth. These critical tasks demand precision, and AI’s exceptional pattern recognition capabilities reduce the risk of human error while maintaining opportunities for experts to validate it. Automated microscopy enables faster, more accurate analyses across industries, from identifying anomalies in medical diagnostics to ensuring the safety of food products.

Key use cases

Automated microscopy drives transformative changes across industries, with three major areas standing out. In medical diagnostics, this technology is revolutionizing disease detection.

“New imaging modalities like Stimulated Raman Spectroscopy and infrared spectroscopy enable analysis without the need for staining, enhancing fields such as anatomopathology. These methods reduce reliance on human inspection, paving the way for AI to address the growing demand for automation in image acquisition and diagnosis,” explains Didier Beghuin, CTO of Lambda-X Verhaert High-Tech. “At Lambda-X, we leverage advanced optical systems to enable breakthroughs in diagnostics. This approach not only enhances accuracy but also accelerates processes critical to patient care. For instance, SoundCell’s systems enable rapid antibiotic susceptibility testing, providing crucial insights into combating bacterial and antimicrobial resistance”.

In the food safety sector, automated image recognition enhances the ability to detect contaminants in products, ensuring rigorous safety standards. Recent advancements highlight how these systems efficiently identify microscopic threats, surpassing the limitations of traditional methods and fostering consumer confidence.

In the biotech industry, automated microscopy plays a pivotal role in processes such as cell counting, where AI can measure cell growth or evaluate the ratio of living to dead cells. These measurements are crucial for testing the effectiveness of new medicines or optimizing bioreactor processes, such as growing fish cells for sustainable food solutions. By combining optics and AI development in parallel, these systems achieve optimal accuracy and performance, reducing human error and accelerating innovation.

Beyond these applications, other industries also benefit from automated microscopy. For instance, water treatment facilities employ these technologies to inspect and analyze samples for contaminants, ensuring compliance with safety regulations and delivering clean water. In the energy sector, automated microscopy aids in material inspections for solar panels and batteries, enhancing durability and efficiency. Similarly, automated systems streamline quality control in the semiconductor industry, where precision sample analysis is crucial for defect detection. These diverse applications underscore the adaptability of automated microscopy in tackling challenges across a broad spectrum of fields.

What sets automated microscopy apart?

Unlike traditional microscopes that rely on human interpretation, automated systems combine advanced hardware—such as spectrometers and fluorescence detectors—with AI-driven image recognition. These technologies enable precise, efficient analysis by identifying patterns and anomalies with a speed and accuracy unattainable through manual methods. Automated microscopy excels in applications where human errors are common, such as counting cells or detecting anomalies in samples. Furthermore, these systems allow for human validation, maintaining a critical balance between automation and oversight.

“AI excels in pattern recognition, making it indispensable in applications like cell counting and anomaly detection,” says Niels Verleysen, AI & data engineer at Verhaert Digital Innovation. “By automating complex tasks, we reduce human error while still enabling expert oversight. This integration of AI into microscopy accelerates processes and opens the door to advanced diagnostics and innovative applications across industries.”

Optics and AI development must go hand in hand to maximize performance. The quality of data gathered by the optical system directly impacts the accuracy of AI models, making an integrated approach essential for achieving superior results. This synergy ensures scalable, high-throughput diagnostics while maintaining reliability and consistency across diverse applications.

The bigger picture

By blending AI with optical engineering, industries are achieving breakthroughs that speed up processes, increase accuracy, and open up advanced use cases. Whether it’s enhancing patient care, ensuring food safety, optimizing biotech processes, or exploring potential components in water inspection, this innovation keeps businesses at the forefront of progress.

As industries pivot toward AI-enabled microscopy, the focus isn’t just on what machines can do, it’s on how they enable people to achieve more.

The post The evolution of microscopy: From human eye to AI appeared first on Verhaert Masters in Innovation.

The post The evolution of microscopy: From human eye to AI appeared first on Verhaert Masters in Innovation.